Banerjee Subhashis sold $99K of ARTV
Banerjee Subhashis (Chief Medical Officer) sold 8,222 shares of Artiva Biotherapeutics, Inc. (ARTV) at $12.01 on 2026-08-27 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The transaction is a routine 10b5‑1 sale; market reaction is expected to be minimal.
Market read
Small insider sale with limited price impact; primarily of interest to shareholders monitoring insider activity.
What to watch
Potential upcoming clinical trial results or partnership announcements that could offset the sale impact.
Background
Form 4 filing discloses insider transactions required by SEC regulations.
Ticker impact
Chief Medical Officer sold 8,222 shares for $98,735, reducing his stake to 142,047 shares.
minor downward pressure, likely within normal volatility range
Sale size is under $100k and represents a modest percentage of holdings; market typically discounts such routine 10b5‑1 sales.
Market effects
No immediate sector impact; biotech peers unlikely to be affected.
U.S. market only; no regional ripple.
Limited global relevance.
Counterpoint
If the CMO is privy to upcoming positive data, the sale could be a pre‑emptive cash‑out before a catalyst.
Key entities
- CompanyArtiva Biotherapeutics, Inc.
Biotech firm developing therapies for rare diseases.
- InsiderBanerjee Subhashis
Chief Medical Officer of Artiva Biotherapeutics.